Yabao Pharmaceutical Group Co., Ltd.

This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. Its chemical structure belongs to cyclized o-methylbenzylamine. Therefore, it does not have the characteristics of non-steroidal anti-inflammatory drugs, nor is it an opioid receptor agonist. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence.

This product is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymine nucleotide, thereby inhibiting DNA biosynthesis. In addition, by preventing uracil and orotic acid from incorporating into RNA, the effect of inhibiting RNA synthesis is achieved. This product is a cell cycle-specific drug that mainly inhibits S-phase cells.

Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions into the cytoplasm and mitochondria, maintaining the normal excitability and internal environment stability of nerve tissue, myocardium, smooth muscle and other cells. It can transport electrolytes to the myocardium, promote myocyte depolarization, maintain myocardial contractility, and reduce myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders.

Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of magnesium ions into the cytoplasm and mitochondria, maintaining the normal excitability and internal environment stability of cells such as nerve tissue, myocardium, and smooth muscle. It can transport electrolytes to the myocardium, promote myocyte depolarization, maintain myocardial contractility, and reduce myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders.

Antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: 1. Interfering with viral DNA polymerase and inhibiting viral replication; 2. Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.

Extract from the above information